Azelaprag
Product Specifications
UNSPSC Description
Azelaprag (Example 263.0) is an apelin receptor agonist agent candidate[1].
Target Antigen
Apelin Receptor (APJ)
Type
Reference compound
Related Pathways
GPCR/G Protein
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/Azelaprag.html
Purity
99.94
Solubility
DMSO : 5 mg/mL (ultrasonic)
Smiles
O=S(NC1=NN=C(C2=CN=CC(C)=C2)N1C(C(OC)=CC=C3)=C3OC)([C@@H](C)[C@@H](C4=NC=C(C)C=N4)C)=O
Molecular Weight
523.61
References & Citations
[1]WO2016187308A1.|[2]Ason B, et.al. Cardiovascular response to small-molecule APJ activation. JCI Insight. 2020 Apr 23;5(8):e132898.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-109111/Azelaprag-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-109111/Azelaprag-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
2049980-18-7
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Bovine T-cell surface glycoprotein CD3 delta chain (CD3D), partial
Recombinant Bovine T-cell surface glycoprotein CD3 delta chain (CD3D), partial
Recombinant Bovine T-cell surface glycoprotein CD3 delta chain (CD3D), partial
Recombinant Bovine T-cell surface glycoprotein CD3 delta chain (CD3D), partial